Suchergebnisse - "Heyward, William L"

PubPharm (51)

1

METHODS AND COMPOSITIONS FOR ELICITING AN IMMUNE RESPONSE AGAINST HEPATITIS B VIRUS

enthalten in: Europäisches Patentamt | 2018

von HEYWARD WILLIAM L

2

Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults

enthalten in: Vaccine | 2018

von Jackson, S. | Lentino, J. | Kopp, J. | +43

3

Methods and compositions for eliciting an immune response against hepatitis B virus

enthalten in: Europäisches Patentamt | 2016

von HEYWARD WILLIAM L

4

Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18-70 years of age

enthalten in: Vaccine | 2015

von Janssen, J. | Jackson, S. | Heyward, W. | +1

5

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitus

enthalten in: Vaccine | 2015

von Janssen, J. | Heyward, W. | Martin, J. | +1

6

Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18-70 years of age

enthalten in: Vaccine | 2015

von Janssen, J. | Jackson, S. | Heyward, W. | +1

7

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitus

enthalten in: Vaccine | 2015

von Janssen, J. | Heyward, W. | Martin, J. | +1

8

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age

enthalten in: Vaccine | 2013

von Heyward, W. | Kyle, M. | Blumenau, J. | +7

CommentIn: Vaccine. 2013 Nov 4;31(46):5297-9. - PMID 24051160

9

Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease

enthalten in: Vaccine | 2013

von Janssen, R. | Mangoo-Karim, R. | Pergola, P. | +6

CommentIn: Vaccine. 2013 Nov 4;31(46):5297-9. - PMID 24051160

10

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age

enthalten in: Vaccine | 2013

von Heyward, W. | Kyle, M. | Blumenau, J. | +7

1
2
3
4
5
6
Nächster »
[6]